170 related articles for article (PubMed ID: 33394629)
1. Influence of the Elipse Intragastric Balloon on Obesity and Metabolic Profile: A Systematic Review and Meta-Analysis.
Ramai D; Singh J; Mohan BP; Madedor O; Brooks OW; Barakat M; Ofosu A; Khan SR; Chandan S; Dhindsa B; Dhaliwal A; Facciorusso A; McDonough S; Adler DG
J Clin Gastroenterol; 2021 Nov-Dec 01; 55(10):836-841. PubMed ID: 33394629
[TBL] [Abstract][Full Text] [Related]
2. The Efficacy and Safety of a Procedureless Gastric Balloon for Weight Loss: a Systematic Review and Meta-Analysis.
Vantanasiri K; Matar R; Beran A; Jaruvongvanich V
Obes Surg; 2020 Sep; 30(9):3341-3346. PubMed ID: 32266698
[TBL] [Abstract][Full Text] [Related]
3. The Elipse Balloon, a swallowable gastric balloon for weight loss not requiring sedation, anesthesia or endoscopy: a pilot study with 12-month outcomes.
Raftopoulos I; Giannakou A
Surg Obes Relat Dis; 2017 Jul; 13(7):1174-1182. PubMed ID: 28372952
[TBL] [Abstract][Full Text] [Related]
4. A prospective pilot study of the efficacy and safety of Elipse intragastric balloon: A single-center, single-surgeon experience.
Al-Subaie S; Khalifa S; Buhaimed W; Al-Rashidi S
Int J Surg; 2017 Dec; 48():16-22. PubMed ID: 28989057
[TBL] [Abstract][Full Text] [Related]
5. Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational, open-label, multicenter study.
Machytka E; Gaur S; Chuttani R; Bojkova M; Kupka T; Buzga M; Giannakou A; Ioannis K; Mathus-Vliegen E; Levy S; Raftopoulos I
Endoscopy; 2017 Feb; 49(2):154-160. PubMed ID: 27951610
[No Abstract] [Full Text] [Related]
6. Feasibility, results and endoscopic requirements of the Elipse® swallowable intragastric balloon: initial experience.
Espinet Coll E; Carrasco Clavijos S; Díaz Galán P; Vila Lolo C; Gómez Valero JA; Bacchiddu S; Irigoyen D; Durán Pastor T; Mora Cubells L; Juan-Creix Comamala A
Rev Esp Enferm Dig; 2019 Dec; 111(12):921-926. PubMed ID: 31599642
[TBL] [Abstract][Full Text] [Related]
7. Intragastric Balloon Treatment for Obesity: Review of Recent Studies.
Tate CM; Geliebter A
Adv Ther; 2017 Aug; 34(8):1859-1875. PubMed ID: 28707286
[TBL] [Abstract][Full Text] [Related]
8. Incidence of nausea and vomiting after intragastric balloon placement in bariatric patients - A systematic review and meta-analysis.
Trang J; Lee SS; Miller A; Cruz Pico CX; Postoev A; Ibikunle I; Ibikunle CA
Int J Surg; 2018 Sep; 57():22-29. PubMed ID: 30031839
[TBL] [Abstract][Full Text] [Related]
9. The Procedureless Elipse Gastric Balloon Program: Multicenter Experience in 1770 Consecutive Patients.
Ienca R; Al Jarallah M; Caballero A; Giardiello C; Rosa M; Kolmer S; Sebbag H; Hansoulle J; Quartararo G; Zouaghi SAS; Juneja G; Murcia S; Turro R; Pagan A; Badiuddin F; Dargent J; Urbain P; Paveliu S; di Cola RS; Selvaggio C; Al Kuwari M
Obes Surg; 2020 Sep; 30(9):3354-3362. PubMed ID: 32279182
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of a Swallowable Intragastric Balloon (Elipse™) on 96 Overweight and Obese Patients.
Taha O; Abdelaal M; Asklany A; Alaa M; Belal S; El Assal I; Shahin M; Abubasha A; Elbanhawy D
Obes Surg; 2021 Mar; 31(3):965-969. PubMed ID: 33118134
[TBL] [Abstract][Full Text] [Related]
11. The Influence of the Orbera Intragastric Balloon Filling Volumes on Weight Loss, Tolerability, and Adverse Events: a Systematic Review and Meta-Analysis.
Kumar N; Bazerbachi F; Rustagi T; McCarty TR; Thompson CC; Galvao Neto MP; Zundel N; Wilson EB; Gostout CJ; Abu Dayyeh BK
Obes Surg; 2017 Sep; 27(9):2272-2278. PubMed ID: 28285471
[TBL] [Abstract][Full Text] [Related]
12. A novel intragastric balloon for treatment of obesity and type 2 diabetes. A two-center pilot trial.
Tønnesen CJ; Hjelmesæth J; Hofsø D; Tonstad S; Hertel JK; Heggen E; Johnson LK; Mathisen TE; Kalager M; Wieszczy P; Medhus AW; Løberg M; Aabakken L; Bretthauer M
Scand J Gastroenterol; 2022 Feb; 57(2):232-238. PubMed ID: 34714203
[TBL] [Abstract][Full Text] [Related]
13. The Safety and Efficacy of Procedureless Gastric Balloon: a Study Examining the Effect of Elipse Intragastric Balloon Safety, Short and Medium Term Effects on Weight Loss with 1-Year Follow-Up Post-removal.
Jamal MH; Almutairi R; Elabd R; AlSabah SK; Alqattan H; Altaweel T
Obes Surg; 2019 Apr; 29(4):1236-1241. PubMed ID: 30613935
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Intragastric Balloons on Obesity-Related Co-Morbidities: A Systematic Review and Meta-Analysis.
Popov VB; Ou A; Schulman AR; Thompson CC
Am J Gastroenterol; 2017 Mar; 112(3):429-439. PubMed ID: 28117361
[TBL] [Abstract][Full Text] [Related]
15. Adverse Events and Complications with Intragastric Balloons: a Narrative Review (with Video).
Ribeiro IB; Kotinda APST; Sánchez-Luna SA; de Moura DTH; Mancini FC; de Souza TF; Matuguma SE; Sakai CM; Rocha RSP; Luz GO; Lera Dos Santos ME; Chaves DM; Franzini TAP; de Moura ETH; de Moura EGH
Obes Surg; 2021 Jun; 31(6):2743-2752. PubMed ID: 33788158
[TBL] [Abstract][Full Text] [Related]
16. The Swallowable Intragastric Balloon Combined with Lifestyle Coaching: Short-Term Results of a Safe and Effective Weight Loss Treatment for People Living with Overweight and Obesity.
Jense MTF; Palm-Meinders IH; Sanders B; Boerma EG; Greve JWM
Obes Surg; 2023 Jun; 33(6):1668-1675. PubMed ID: 37012502
[TBL] [Abstract][Full Text] [Related]
17. Single Fluid-Filled Intragastric Balloon Safe and Effective for Inducing Weight Loss in a Real-World Population.
Vargas EJ; Pesta CM; Bali A; Ibegbu E; Bazerbachi F; Moore RL; Kumbhari V; Sharaiha RZ; Curry TW; DosSantos G; Schmitz R; Agnihotri A; Novikov AA; Pitt T; Dunlap MK; Herr A; Aronne L; Ledonne E; Kadouh HC; Cheskin LJ; Mundi MS; Acosta A; Gostout CJ; Abu Dayyeh BK
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1073-1080.e1. PubMed ID: 29425781
[TBL] [Abstract][Full Text] [Related]
18. Clinical safety and effectiveness of a swallowable gas-filled intragastric balloon system for weight loss: consecutively treated patients in the initial year of U.S. commercialization.
Moore RL; Seger MV; Garber SM; Smith AB; Nguyen RT; Shieh MK; Snow RG; Sullivan S
Surg Obes Relat Dis; 2019 Mar; 15(3):417-423. PubMed ID: 30797717
[TBL] [Abstract][Full Text] [Related]
19. Fluid-filled intragastric balloons are an effective and safe weight loss option across BMI and age ranges.
Marrero Torres RJ; Gregory F; Micames CG
Surg Endosc; 2022 Jul; 36(7):5160-5166. PubMed ID: 34845556
[TBL] [Abstract][Full Text] [Related]
20. Intragastric Balloon Significantly Improves Metabolic Parameters at 6 Months: a Meta-Analysis.
Shah RH; Vedantam S; Kumar S; Amin S; Pearlman M; Bhalla S
Obes Surg; 2023 Mar; 33(3):725-732. PubMed ID: 36633759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
